1-3 of 3
Sibylle Dames
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SLN140 a Small Interfering RNA Targeting Protein S Improves Hemostasis Potency in Hemophilia

Raja Eladnani Prince, Ute Schaeper, Julia Aretz, Bojun Li, Maria Desiré Reina Caro, Kristina vrotniakaite-Bajerciene, Mona Eisermann, Sibylle Dames, Kathrin Löffner, Alberto Martinez, Michael Laffan, Josefin Ahnstrom, Anne Angelillo-Scherrer
Journal: Blood
Blood (2022) 140 (Supplement 1): 1670–1671.
https://doi.org/10.1182/blood-2022-169029
Published: 2022
Journal Articles

Targeting Protein S Using Small Interfering RNA Is Well Tolerated and Protects Mice with Hemophilia a from Acute Hemarthrosis

Raja Eladnani Prince, PhD, Ute Schaeper, Sibylle Dames, Sara Calzavarini, PhD, Claudia Quarroz, BMA, Maria Desiré Reina Caro, BMA, Astrid Chanfon Bätzner, Kathrin Löffner, Mona Eisermann, Anne Angelillo-Scherrer, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-138692
Published: 2020
Journal Articles

SLN124, a Galnac-siRNA Conjugate Targeting TMPRSS6, for the Treatment of Iron Overload and Ineffective Erythropoiesis Such As in Beta-Thalassemia

Sandro Altamura, PhD, Sandro Altamura, PhD, Martina U. Muckenthaler, PhD, Sibylle Dames, MSc, Christian Frauendorf, PhD, Steffen Schubert, PhD, Manuela Aleku, MSc, Jim Vadolas, PhD, George Grigoriadis, MBBS PhD FRACP FRCPA, Ulrich Zügel, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2340.
https://doi.org/10.1182/blood-2018-99-110163
Published: 2018